Re-screening for novel CD40-TRAF6 interaction inhibitors (TRAF-STOPs 2.0)

- Project Term
- 2021 - 2021
- Granted Budget
- € 405.710
- Indication
- atherosclerosis
- Therapeutic Principle
- Drug
- Principal Investigator
- Dorothee Atzler, Christian Weber, Esther Lutgens (Hospital of Ludwig Maximilian University of Munich)